Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / March / Why Glaucoma Prevalence Is Rising
Glaucoma Insights Opinions

Why Glaucoma Prevalence Is Rising

... and what the eye care community must do next

By Don Railsback 3/24/2026 2 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Top Institutions
  • Top Thought Leaders

Clinical Report: Why Glaucoma Prevalence Is Rising

Overview

Glaucoma prevalence is projected to rise significantly, particularly among older adults and diverse populations. Factors contributing to this trend include an aging population, increased diagnostic awareness, and higher risks among certain racial and ethnic groups.

Background

Glaucoma is a leading cause of irreversible vision loss, making its rising prevalence a critical public health concern. The condition often progresses silently, leading to late diagnosis and treatment. Understanding the demographic shifts and risk factors associated with glaucoma is essential for effective prevention and management strategies.

Data Highlights

No specific numerical data provided in the article.

Key Findings

  • Projected increase to 1.6 million glaucoma cases in individuals over 40 by 2060.
  • Higher risk of glaucoma in individuals over 40, particularly after age 60.
  • Significant risk factors include family history, elevated intraocular pressure, and systemic diseases.
  • Certain racial and ethnic groups, including African, Hispanic, and Asian populations, have a higher lifetime risk of glaucoma.
  • Comprehensive eye exams are crucial for early detection and management of glaucoma.

Clinical Implications

Healthcare providers must prioritize regular comprehensive eye exams, especially for at-risk populations. Increased awareness and accessibility to eye care services are essential to mitigate the rising burden of glaucoma and prevent vision loss.

Conclusion

Addressing the rising prevalence of glaucoma requires a multifaceted approach, including improved access to care and heightened awareness of the importance of early detection. Proactive measures can significantly impact patient outcomes.

References

  1. Dianna Liu, MD, Ophthalmology Management, 2016 -- Glaucoma’s growing prevalence in the US
  2. The Ophthalmologist, 2026 -- UK: More than a Million Over 40s Living with Glaucoma
  3. Glaucoma Physician, 2026 -- Closing the Gap Between Glaucoma Diagnosis and Intervention
  4. Optometric Management, 2008 -- Preventing Blindness Due to Glaucoma
  5. Scholars@Duke publication -- Primary Open-Angle Glaucoma Preferred Practice Pattern®
  6. Scholars@Duke publication: Primary Open-Angle Glaucoma Preferred Practice Pattern®.
  7. Clinical Application of the 20-Year Results from the Ocular Hypertension Treatment Study - PubMed
  8. Frontiers | Global trends and disparities in burden of blindness and vision loss caused by non-communicable diseases from 1990 to 2021, and forecasts to 2045: a systematic analysis for the global burden of disease study 2021

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: